Treating Early-Stage Lung Cancer
CME Monograph - September 2007
This educational monograph was developed for oncologists, thoracic surgeons, radiologists and other medical professionals who assess, counsel, and treat lung cancer patients. Program faculty are Thomas J. Lynch, Jr., MD, Chief Oncology/ Hematology, MGH Cancer Center, Armin Ernst, MD, FCCP, Chief, Interventional Pulmonology, Beth Israel Deaconess Medical Center, Michael Lanuti, MD, Department of Thoracic Surgery, Massachusetts General Hospital, Damian E. Dupuy, MD, Department of Diagnostic Imaging, Brown University Christopher G. Azzoli, MD, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Rebecca Suk Heist, MD, MPH, Department of Oncology, Massachusetts General Hospital Cancer Center, and David H. Harpole, Jr., MD, Chief, Division of Surgery, Duke University Medical Center.
The educational objectives are to discuss treatment options for early-stage lung cancer patients including: key elements of a preoperative workup; pros/cons of using radiofrequency ablation to treat poor surgical risk patients; appropriate use of chemotherapy and radiation therapy in stage II and III lung cancer; appropriate use of chemotherapy in treating stage Ia and Ib lung cancer; and information needed to assess potential future role of adjuvant targeted therapy. The program was supported by educational grants from industry. Program management and CME sponsorship were provided by InforMEDical.
